Although ALK fusions are less common in other tumor types, they have been occasionally detected in sarcomas, neuroblastoma, and esophageal, renal, breast, ovarian, thyroid, and colorectal cancers (Ross et al., 2017). This evidence concerns the gene ALK and neuroblastoma.